Kontour Medical(SH:688314) Zheng Quan Zhi Xing·2025-05-21 09:18Core Viewpoint - The announcement details the public disclosure and verification of the incentive plan for restricted stock for the year 2025 by Xi'an Kangtuo Medical Technology Co., Ltd, ensuring compliance with relevant regulations and confirming the qualifications of the proposed incentive recipients [2][3][4]. Disclosure and Verification - The company held meetings on April 28, 2025, to approve the draft of the 2025 restricted stock incentive plan and related proposals, which were disclosed on the Shanghai Stock Exchange website [2]. - The public disclosure period for the proposed incentive recipients was from May 6 to May 15, 2025, during which no objections were raised [3]. - The supervisory board verified the qualifications of the proposed recipients against various legal and regulatory standards, confirming that they meet the necessary criteria [3][4]. Supervisory Board's Verification Opinion - The supervisory board concluded that all proposed incentive recipients meet the qualifications set forth by the Company Law, Securities Law, and other relevant regulations, confirming their eligibility for the incentive plan [4][5].